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Abstract 
Purpose: To investigate the spasmolytic and laxative properties of Buxus sempervirens Linn 
(Buxaceae) in rabbits and mice. 
Methods:  Aqueous methanol extract (AqMeBS) as well as the dichloromethane (DCMF) and aqueous 
(AqF) fractions of Buxus sempervirens were investigated on isolated rabbit jejunum to explore its 
antispasmodic effect, relative to the standard drug, verapamil. Laxative and prokinetic potentials of 250 
and 500 mg/kg doses of AqMeBS extract were evaluated in mice and compared to that of negative 
(normal saline) and positive (carbachol) control groups. The effects of AqMeBS and carbachol were 
also tested in mice pretreated with atropine (10 mg/kg). Single dose, acute oral toxicity study on 
AqMeBS was also executed in mice at 4000, 8000 and 12000 mg/kg doses.  
Results: AqMeBS, DCMF and AqF significantly inhibited the rhythmic contractility of jejunum with 
0.961, 0.0327 and 0.242 mg/mL, respectively, as median effective concentrations (EC50). In addition, 
AqMeBS, DCMF and AqF significantly relaxed the contractions due to K+, with EC50 of 1.85, 0.05 and 
1.07 mg/mL, respectively. Ca2+ concentration response curves (CCRCs) were shifted to the right by 
AqMeBS and DCMF, in the same manner as verapamil. In the in vivo experiments, AqMeBS produced 
significant (p < 0.0001) laxative and prokinetic effects at 250 and 500 mg/kg doses and was comparable 
to that of carbachol. The acute toxicity study showed that AqMeBS was associated with one mortality at 
the highest tested dose (12000 mg/kg). 
Conclusion: These results provide the pharmacological basis for the traditional use of B. sempervirens 
Linn as a laxative and prokinetic remedy in the management of constipation.  
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Buxus sempervirens known in Pakistan as 
paapari and is an evergreen tree widespread, 
especially in the Swat area of Pakistan. This 
Himlalayas plant is characterized by its elliptic-
shaped leaves and tetragonal shoots [1]. The 
evergreen plants of B. sempervirens are 
popularly used for the decorative purpose. The 
plant is used in folkloric medicine for the 
treatment of alopecia, neoplasm, seizures, liver 
diseases (Hepatitis), malaria, pyrexia, 
pneumonia, skin irritation, arthritis and stomatitis. 
It is also used as an astringent, cardiac stimulant 
and purgative. It is also used for the 
management of constipation, skin disorders, 
hyperuricemia, hypertension, immobility, tetanus 
and infections caused by mycobacterium [2]. 
Several alkaloids e.g. semperviraminol, 
buxamine F, 17-oxocycloprotobuxine, buxoxy-
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benzamine, buxapapillinine and cyclobuxine-D 
have been isolated from B. sempervirens [3]. The 
plant also exhibits several pharmacological 
activities such as anticancer [4], anti-protozoal, 
antioxidant, anti-malarial, anti-cholinesterase and 
tyrosinase- inhibitory effects [5].  
 
The objective of present study was to investigate 
the spasmolytic, prokinetic and laxative potential 




Chemicals and drugs 
 
Ethylene-diamine-tetra-acetic acid (EDTA), 
potassium chloride (KCl), carbachol, atropine 
and acetylcholine were products of Sigma®. All 
other chemicals were also of analytical grade 
and acquired from BDH® and Merck®.  
 
Preparation of crude extract and fractions 
 
Fresh aerial parts of B. sempervirens were from 
the Swat valley in 2014. Authentication of the 
plant was done in University of the Punjab, 
Lahore by a taxonomist Dr. Niazi, (who assigned 
a voucher no. 252014) and the sample was 
submitted to the departmental herbarium. The 
aerial portion was dried and pulverised. The 
powdered sample was then extracted in 
aqueous-methanol (30:70 volume ratio of water : 
methanol) to produce an extract yield of 10.075 
%.  The extract (AqMeBS, 50 g) was then 
dissolved in enough distilled water and an equal 
volume of dichloromethane (DCM) was added to 
it. The extraction was repeated thrice, and the 
resultant extracts were combined and 
concentrated with a rotary evaporator (model 
9230, BUCHI Switzerland) at 37 °C. The 
aqueous part was lyophilized to yield AqF. The 
yield of AqF was 21.6 %, while that of DCMF was 
78.4 % [6]. 
 
Phytochemical screening  
 
Phytochemical evaluation of AqMeBS was 
performed according to the standard methods 
described earlier [7].  
 
Experimental animal conditions 
 
Mature, local breed of rabbits (mean weight = 1.5 
kg) and albino mice (Swiss breed, weight: 20 - 25 
g) of both sexes were procured from a supplier in 
Multan. The rabbits and mice were housed under 
standardized conditions at 25 ± 1 °C and 
provided unrestricted access to balanced diet 
(Hi-Tech Feeds Pvt. Ltd. Lahore) and clean 
drinking water. The animals were fasted 
overnight prior to commencement of the study. 
The rabbits were anesthetized with chloroform 
and sacrificed by cervical dislocation to excise 
jejunum for use in in vitro experimentations. All 
experimental procedures were according to the 
directives of the Institute of Laboratory Animal 
Resources, Commission on Life Sciences [8]. 
Approval (EC/05PhDL/2013) was obtained from 
the Animal Ethics Committee of Bahauddin 
Zakariya University, Multan. 
 
Evaluation of in vitro anti-spasmodic effect 
 
The anti-spasmodic activities of AqMeBS, DCMF 
and AqF were investigated in isolated rabbit 
jejunum preparation. A 2-3 cm portion of the 
jejunum was placed in an organ bath containing 
15 mL Tyrode’s solution. The composition of 
Tyrode’s solution (mM) was: sodium chloride 
(136.9), KCl (2.68), sodium bicarbonate (11.90), 
magnesium chloride (1.05), sodium dihydrogen 
phosphate (0.42), calcium chloride (1.8) and 
glucose (5.55). The tissue was kept at normal 
body temperature and aerated using carbogen 
gas (95 % oxygen and 5 % carbon dioxide). 
Each jejenum tissue was subjected to pre-load of 
1g and allowed to stabilize for half an hour. Then 
doses of test material were administered in a 
cumulative manner after every 10 min. A 
rhythmic contractility was detected in each 
jejunum preparation which allowed the 
assessment of relaxing potential of the extracts 
(0.03-3 mg/mL AqMeBS; 0.03-0.1 mg/mL DCMF 
and 0.03-3 mg/mL AqF) in the absence of 
agonist. Isotonic transducers were used to record 
the rhythmic contractions via a Power Lab (AD 
Instruments, Australia) [9]. 
 
Determination of in vitro calcium channel 
blocking effect 
 
The aqueous methanolic extract (AqMeBS) and 
its dichloromethane fraction (DCMF) were further 
investigated to ascertain the mechanism 
underlying their effects. On exposure to 80mM 
K+, the isolated jejunum produced sustained 
contractility through voltage-dependent calcium 
channels (VDCs) [10]. Isolated jejunum 
preparations were subjected to the solutions of 
test extracts which exerted concentration 
dependent inhibition in contractility. This 
inhibition in contractility was compared to that of 
verapamil, a calcium channel blocker. The 
inhibition in contractility with calcium channel 
blocker was validated in isolated jejunum. The 
isolated jejunum was steadied in Tyrode’s 
solution and was then substituted with calcium 
free Tyrode’s solution (comprising of the 
constituents as that of Tyrode solution, however, 
lacks in calcium chloride). Thereafter, the 
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calcium free Tyrode’s solution was replaced with 
EDTA-rich, Ca2+-free Tyrode’s solution 
(comprising of the same constituents as that of 
calcium free Tyrode solution, however, contains 
EDTA, 0.1 mM). Calcium chloride (0.01 and 0.1 
mM) was added to the organ bath after 30 
minutes, in accumulative manner to attain control 
Ca2+ concentration response curves (CRCs). The 
trial was repeated multiple times until alike Ca2+ 
control CRCs were obtained. The tissues were 
then rinsed and equilibrated with AqMeBS and 
DCMF for 45 mins. Thereafter, Ca2+ CRCs 
produced in response to varying dilutions of 
AqMeBS, DCMF and verapamil were constructed 
and matched with control CRCs [11]. 
 
Determination of laxative effect in albino mice 
 
Seven groups of mice were used (n=5). Mice in 
negative control group were orally administered 
with 10 ml/Kg normal saline. Mice in positive 
control Group were given the laxative, cabachol 
(1 mg/kg) through intraperitoneal route. Doses of 
250 and 500 mg/ Kg AqMeBS were administered 
to the mice in group 3 and 4 respectively. Mice, 
pretreated with intraperitoneal atropine (10 
mg/Kg) were subdivided into group 5, 6 and 7 
that subsequently received 1 mg/Kg carbachol 
and 250 and 500 mg/Kg AqMeBS extract 
respectively. The total number of droppings and 
total number of moist droppings in all the groups 
were recorded after 6 hours. The increase in 
moist droppings comparative to the total 
droppings was an indicative of laxative effect 
[12]. 
 
Evaluation of gastrointestinal motility  
 
The mice were randomly divided into seven 
groups. These were kept overnight with an 
access to water, however, were devoid of any 
food. In group 1 (negative control), 1 mL normal 
saline was given to the mice p.o. Group II mice 
(positive control) received 1 mg/kg CCh i.p., 
while mice in groups 3 and 4 received 250 and 
500 mg /Kg of AqMeBS (p.o), respectively. The 
acetylcholine-like prokinetic properties of 
carbachol and AqMeBS were also studied. Mice 
in groups 5, 6 and 7 received 10 mg/kg atropine 
i.p 15 min before treatment with carbachol (1 
mg/Kg) and AqMeBS (250 and 500mg/Kg) 
respectively. 30 minutes post administration of 
initial therapy, each mouse also received 1 mL (5 
% w/v) charcoal suspension consisting of (0.5 
%w/v) methyl cellulose. These were anesthetized 
with chloroform and sacrificed 30 minutes after 
the charcoal meal. A percentage of intestinal 
propulsion (an index of distance moved by the 
charcoal) was calculated as outlined earlier [13]. 
 
% Intestinal propulsion = Distance traveled by 
charcoal diet (cm)/total length of small intestine 
(cm) ×100 
 
Acute toxicity Study 
 
Four groups of mice were used (n=5, one group 
per cage). The acute toxicity study was carried 
out at 25 ± 01 °C and 12 hour in a well-aerated 
room with 12 h/12 h day/night cycle. The mice 
were fasted overnight however, had free access 
to water. Mice in group 2, 3 and 4 were given a 
single oral dose of 4000, 8000 and 12000 mg/Kg 
respectively, while, mice in group 1 received 10 
ml/Kg normal saline orally. Mice in all the groups 
were monitored non-stop for the first 48 h, for 
toxicity signs such as mortality, behavioral 
changes and weight changes. The monitoring 
continued for 14 days [14]. All observed toxicity 




Data from laxative and prokinetic studies were 
analyzed with one-way ANOVA using Graph Pad 
Prism® version 6 (San Diego, California USA). P 
< 0.0001 was taken as indicative of statistically 
significant differences. Data from in-vitro 
experiments were shown as mean ± Standard 
error of mean (SEM). EC50 was determined from 





Phytochemical profile  
 
The results of phytochemical investigations are 
presented in Table 1. 
 
Table 1: Phytochemical profile of Buxus sempervirens 
Linn extract 
 
Secondary metabolites Result 
Alkaloids Present 






Assessment of in-vitro antispasmodic effect 
 
AqMeBS induced spasmodic activity at 0.1-1 
mg/mL dose, which was followed by anti-
spasmodic action at 3 mg/mL dose. The 
spasmodic effect was entirely blocked by pre-
treatment with 3 µM atropine (Figure 1). 
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       Figure 1: Anti-spasmodic effect of AqMeBS in the absence and presence of atropine. 
 
AqMeBS and AqF relaxed the rabbit jejunum 
contractions at doses of 0.01 - 0.1 mg/mL, 
showed 0.032 mg/mL EC50 (95 % CI = 0.022 - 
0.04) while 0.01 - 3 mg/mL showed EC50 = 0.24 
mg/mL (95 % CI = 0.15 - 0.38), respectively.  
 
AqMeBS, DCMF and AqF relaxed dose-
dependently, the potassium (80 mM)-induced 
contraction with EC50 values of 1.85 mg / mL 
(95% CI = 1.5 - 2.1), 0.05 mg / mL (95% CI = 
0.03 - 0.09), and 1.07 mg / mL (95% CI = 0.75 - 
1.5), respectively. The corresponding EC50 for 
verapamil was 0.82 mg / mL (95% CI = 0.82 to 
0.82). These results are shown in Figure 2. 
 
In vitro calcium channel blocking effect 
 
AqMeBS and DCMF shifted the CRCs to the 
right at 0.3 – 3 mg/mL and 0.03 - 0.3 mg/mL, 
respectively, in a manner similar to the shift 
produced by 0.1 - 1µM verapamil (Figure 3). 
 
Laxative effect  
 
A high number of wet droppings resulted from 
administering 250 and 500 mg/Kg doses of 
AqMeBS [51.67 ± 3.73 % (***p < 0.001) and 
64.70 ± 2.59 % (****p < 0.0001)], respectively. 
However, carbachol administration resulted in 
the highest wet droppings [73.9 ± 3.85 % (****p < 
0.0001)]. In comparison, prior administration of 
atropine resulted in significant decreases in the 
amount of wet droppings in the AqMeBS group. 
The atropine-induced reduction in wet droppings 
was most pronounced in the CCh group [9 ± 5.18 
% (****p < 0.0001)]. These results are shown on 
Table 2. 
 
Effect of extracts on intestinal transit  
 
Prokinetic effect was produced by AqMeBS at 
250 and 500 mg/kg as evidenced by the 
intestinal movement of the charcoal meal. The 
charcoal meal traveled the least distance in the 
group given saline (56.6 ± 0.4 %). Intestinal 
transit was significantly increased by CCh (92.2 ± 
1.11 %, p < 0.0001). 250mg/kg dose of AqMeBS 
produced 64 ± 0.32 % (p < 0.001) whereas, 
500mg/Kg dose of AqMeBS produced 77.4 ± 0.6 
% intestinal propulsions (p < 0.0001). However, 
the prokinetic activities of AqMeBS and 
carbachol were significantly attenuated by prior 
treatment with 10 mg/kg atropine. These results 
are presented in Figure 4. 
Figure 2: Relaxant effect of AqMeBS, DCMF, AqF and verapamil in rabbit jejunum. (a) Sponteneous: 
AqMeBS ( ), AqF ( ), DCMF ( ); (b) Against pottasium (80 mM)-induced contraction: AqMeBS ( ) 
AqF ( ) DCMF ( ); (c) Verapamil: sponteneous ( ), K+ (80 mM)-induced contraction ( ) 
Hamid & Janbaz 




Figure 3:  Effect of (a) AqMeBS: control ( ), 0.3 mg/mL I mg/mL ( ) ( ), 3mg/mL ( ); (b) DCMF: 
control ( ), 0.03mg/mL ( ) 0.1 mg/mL ( ), 0.3 mg / mL ( ); (C) Verapamil: control ( ), 0.03 µM/mL 
( ), 0.1 µM / mL ( ) and 0.03mg/mL ( ) on CRCs of rabbit jejunum. 
 
Table 2: Laxative property of AqMeBS 
 
Treatment Mean defecation/ group 




Normal saline p.o, (10 mL/kg) 3.4 ± 0.24 0 0 
Carbachol intraperitoneal (1 mg/kg). 13.8 ± 0.37**** 10.2 ± 0.37**** 73.9 ± 3.85 
AqMeBS p.o, (250 mg/kg) 6.2 ± 0.37**** 3.2 ± 0.2*** 51.67 ± 3.73 
AqMeBS p.o, (500 mg/kg) 11.6 ± 0.24**** 7.5 ± 0.15**** 64.70 ± 2.59 
CCh intraperitoneal (1mg/kg) + atropine 
intraperitoneal (10mg/kg) 
4.4 ± 0.24**** 0.4 ± 0.1**** 9 ± 5.18 
AqMeBS p.o, (250mg/kg) + atropine intraperitoneal 
(10 mg/kg) 
4.7 ± 0.2** 1.6 ± 0.1*** 34.17 ± 4.49 
AqMeBS p.o, (500mg/kg) + atropine intraperitoneal 
(10mg/kg, i.p.) 
4.2 ± 0.37**** 0.7 ± 0.12**** 16.33 ± 3.75 
Note: * showed the significance in comparison of group 2, 3 and 4 against control group 1 at p < 0.05; ** showed 
the significance in comparison of group 5 against carbachol group at p < 0.01; *** showed the significance in 
comparison of groups 2, 3 and 4 against control group 1 at p < 0.001; **** showed the significance in comparison 
of group 6 against 250 mg/kg AqMeBS group and group 7 against 500 mg/kg AqMeBS group at p < 0.0001. Data 




No signs or symptoms of toxic effects were seen 
in the mice treated with AqMeBS at a dose of 
4000 mg /kg. However, minor toxicity signs were 
noticed in the groups that received doses of 8000 
and 12000 mg/kg, although these signs receded 




The traditional use of B. sempervirens as a 
laxative and spasmolytic [2,15] formed the bases 
of this study. Results from phtochemical analysis 
showed that AqMeBS contains flavonoids, 
tannins, alkaloids and saponins. These 
phytochemicals may be responsible for the 
traditional and medicinal application of this plant 
[16]. This study has demonstrated that B. 
sempervirens possesses antispasmodic and 
prokinetic activities. Similar results were obtained 
in studies on Buxus wallichiana (a plant in the 
same genus) which is used for treating 
gastrointestinal, cardiovascular and respiratory 
illnesses [15]. 
 
The mechanism underlying the laxative potential 
of AqMeBS in mice was revealed by the 
concentration-dependent, extract-induced 
contractility of rabbit jejenum, which was inhibited 
by atropine. The increase in jejenum contractility 
might be due to the stimulatory influence of some 
phytochemical components of Buxus 
sempervirens on intestinal muscarinic receptor 
[17]. The candidate compounds are probably 
more abundant in DCMF, which inhibited jejunum 
contractility most. It has been suggested that the 
spasmolytic properties of herbal extracts may be 
a consequence of inhibition of calcium channels 
[18].  Studies have established unequivocally 
that potassium ions open voltage-gated calcium 
channels, a process that triggers influx of  
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Figure 4: Effect of AqMeBS on gastrointestinal motility of charcoal meal, with or without atropine.  
* p < 0.05, ** p < 0.01; *** p < 0.001; **** p < 0.0001. Results are expressed as mean ± SEM (n = 5) 
 




Mice Mortality               Signs of toxicity 
  
Contro l (normal saline, 
10 ml/kg) 
5 0 None 
4000 mg/kg AqMeBS 5 0 None 
8000 mg/kg AqMeBS 5 0 No sign or symptom of toxicity were witnessed within six 
hours of dosing. On second day, ruffled skin, piloerection, 
more defeces and increased urination were observed. 
12000 mg/kg AqMeBS 5 1 at day six  Decreased physical activity, depressed mood, 
piloerection, anal  swelling and bleeding were witnessed 
four hours after administration 
 
extracellular Ca2+ resulting in enhancement of 
smooth muscle contractility [19]. The effect of 
AqMeBS was evident from the shifting of the 
CRCs to right, an effect resembling that of the 
calcium channel blocker, verapamil. More potent 
effects were produced by DCMF and verapamil 
than AqMeBS fraction. This is consistent with the 
superior jejenum contractile responses seen in 
this fraction, relative to AqMeBS. Again, this 
effect suggests that DCMF contains more potent 
calcium channel-blocking agents than AqMeBS.  
 
The results acquired in this study showed that 
AqMeBS possesses laxative properties 
comparable to that of carbachol, an agent which 
enhances motility of the small intestine [20]. The 
laxative effect of AqMeBS was inhibited partially 
by atropine, an established antagonist of 
muscarinic receptor. Atropine blocks cholinergic 
nicotinic receptor in the intestine where the 
release of acetylcholine from myenteric plexus 
activates cholinergic receptors [21].  The 
inhibition of the laxative effect of AqMeBS by 
atropine suggests that the extract may contain 
compounds that exert the same effects as 
acetylcholine. Acetlycholine increases 
gastrointestinal contraction by stimulating 
muscarinic receptors in a process mediated by 
G-protein, phospholipase C and inositol 
triphosphate [22]. Previous studies have also 
reported that B. sempervirens extract inhibited 
the activities of butrylcholinesterase and 
acetylcholinesterase [23]. These findings strongly 
suggest that some components of AqMeBS may 
have cholinergic properties, which are 
responsible for blockage of the activity of  
acetylcholinesterase [24]. Indeed, some 
parasympathomimetic alkaloids and tannins have 
been reported in B. sempervirens [16]. Thus the 
presence of acetylcholine-like components may 
be responsible for the cholinergic activity of B. 
sempervirens [25].  
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Results from oral acute toxicity study in mice 
revealed that the lethal dose for 50 percent 
animals was more than 12000 mg/kg. The weight 
loss recorded may be due to the saponins in the 
extract. It has been reported that saponins may 
be implicated in loss of weight in some 




The findings of this study show that B. 
sempervirens Linn exhibit laxative, prokinetic and 
antispasmodic potential. These results may lend 
some pharmacological justification for the 
traditional use of the plant in constipation and 
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